Evidence-Based Medicine Guidelines
Immunomodulators and immunosuppressants for relapsing-remitting multiple sclerosis (RRMS): a network meta-analysis
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Immunomodulators and Immunosuppressants for Relapsing-remitting Multiple Sclerosis (RRMS): a Network Meta-analysis." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/458472/all/Immunomodulators_and_immunosuppressants_for_relapsing_remitting_multiple_sclerosis__RRMS_:_a_network_meta_analysis.
Immunomodulators and immunosuppressants for relapsing-remitting multiple sclerosis (RRMS): a network meta-analysis. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/458472/all/Immunomodulators_and_immunosuppressants_for_relapsing_remitting_multiple_sclerosis__RRMS_:_a_network_meta_analysis. Accessed October 6, 2024.
Immunomodulators and immunosuppressants for relapsing-remitting multiple sclerosis (RRMS): a network meta-analysis. (2019). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/458472/all/Immunomodulators_and_immunosuppressants_for_relapsing_remitting_multiple_sclerosis__RRMS_:_a_network_meta_analysis
Immunomodulators and Immunosuppressants for Relapsing-remitting Multiple Sclerosis (RRMS): a Network Meta-analysis [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2024 October 06]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/458472/all/Immunomodulators_and_immunosuppressants_for_relapsing_remitting_multiple_sclerosis__RRMS_:_a_network_meta_analysis.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Immunomodulators and immunosuppressants for relapsing-remitting multiple sclerosis (RRMS): a network meta-analysis
ID - 458472
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/458472/all/Immunomodulators_and_immunosuppressants_for_relapsing_remitting_multiple_sclerosis__RRMS_:_a_network_meta_analysis
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -
